High her2/centromeric probeforchromosome17fluorescence insitu hybridization ratio predicts pathologic complete response and survival outcomein patients receiving neoadjuvant systemic therapy with trastuzumab for her2-overexpressing locally advanced breast cancer

Takahiro Kogawa, Tamer M. Fouad, Diane D. Liu, Jimin Wu, Yu Shen, Hiroko Masuda, Takeo Fujii, Mariana Chavez-Macgregor, Ricardo H. Alvarez, Gabriel N. Hortobágyi, Vicente Valero, Naoto T. Ueno

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'High her2/centromeric probeforchromosome17fluorescence insitu hybridization ratio predicts pathologic complete response and survival outcomein patients receiving neoadjuvant systemic therapy with trastuzumab for her2-overexpressing locally advanced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences